BCBP.NASDAQBcb Bancorp INC

10-Q: BCB Bancorp Reports Q2 Profit Amid Rising Loan Losses

Sentiment:

Quarterly Report


BCB Bancorp, Inc. reported a net loss for the first half of 2025, primarily due to a significant increase in loan loss provisions, despite a slight improvement in net interest margin.

Capital raiseCompleted a private placement of 52 shares of Series K 6.0% Noncumulative Perpetual Stock on March 15, 2025, resulting in gross proceeds of $520,000.Completed a private placement of 497 shares of Series K Preferred Stock on December 31, 2024, resulting in gross proceeds of $4,970,000.Closed a private placement of 136 shares of Series J Noncumulative Perpetual Stock on September 25, 2024, resulting in gross proceeds of $1,360,000.Closed a private placement of 67 shares of Series J Noncumulative Perpetual Stock on June 21, 2024, resulting in gross proceeds of $670,000.Closed a private placement of 269 shares of Series J Noncumulative Perpetual Stock on March 29, 2024, resulting in gross proceeds of $2,690,000.Closed a private placement of 1,527 shares of Series J Noncumulative Perpetual Stock on December 14, 2023, resulting in gross proceeds of $15,270,000.
Worse than expectedThe company reported a net loss of $4.8 million for the first six months of 2025, a significant decline from net income in the prior year period.Provision for credit losses increased by $21.2 million, primarily due to a large specific reserve for a cannabis loan and increased reserves for the Business Express Loan portfolio.Non-accrual loans more than doubled, indicating a substantial deterioration in asset quality.

Summary

  • BCB Bancorp, Inc. reported a net loss of $4.8 million for the six months ended June 30, 2025, a significant decline from a net income of $8.7 million in the same period of 2024.
  • Basic earnings per share turned negative to $(0.33) for the first half of 2025, down from $0.46 in the prior year period.
  • Total assets decreased by $218.7 million, or 6.1%, to $3.380 billion at June 30, 2025, from $3.599 billion at December 31, 2024.
  • Loans receivable, net, decreased by $135.8 million, or 4.5%, to $2.860 billion.
  • The provision for credit losses surged to $25.7 million for the first six months of 2025, a 468.9% increase from $4.5 million in the same period of 2024.
  • This increase included a $13.7 million specific reserve tied to a cannabis sector loan and a $3.1 million increase for the Business Express Loan portfolio.
  • Non-accrual loans more than doubled to $101.8 million, or 3.50% of gross loans, at June 30, 2025, compared to $44.7 million, or 1.48% of gross loans, at December 31, 2024.
  • Net charge-offs increased to $9.9 million for the first six months of 2025, up from $2.9 million in the comparable 2024 period.
  • The allowance for credit losses increased to $50.7 million, or 1.74% of gross loans, at June 30, 2025, from $34.8 million, or 1.15% of gross loans, at December 31, 2024.
  • Total deposits decreased by $89.3 million, or 3.2%, to $2.662 billion.
  • FHLB advances decreased by $119.7 million to $335.6 million, reflecting a reduction in wholesale funding.
  • Net interest margin improved to 2.70% for the first six months of 2025, up from 2.55% in the same period of 2024, driven by a decrease in the cost of interest-bearing liabilities.
  • Stockholders' equity decreased by $8.2 million, or 2.5%, to $315.7 million.
  • The company completed private placements of Series K preferred stock totaling $520,000 in March 2025 and $4,970,000 in December 2024, and Series J preferred stock totaling $1,360,000 in September 2024, $670,000 in June 2024, $2,690,000 in March 2024, and $15,270,000 in December 2023.
  • The Board of Directors declared a cash dividend of $0.16 per common share payable on August 25, 2025.

Sentiment

Score: 3

Explanation: The company reported a net loss for the first half of the year, driven by a substantial increase in loan loss provisions and a significant rise in non-accrual loans, indicating deteriorating asset quality. While net interest margin improved and capital ratios remain strong, the credit quality headwinds, particularly in the cannabis and Business Express loan portfolios, present significant concerns for future profitability and outweigh the positive aspects.

Positives

  • Net income for the second quarter of 2025 increased to $3.6 million from $2.8 million in Q2 2024, primarily due to the absence of a $4.9 million loss on loan sales recorded in the prior year quarter.
  • Net interest margin improved to 2.80% for Q2 2025 (from 2.60% in Q2 2024) and 2.70% for 6M 2025 (from 2.55% in 6M 2024), driven by a decrease in the average rate paid on interest-bearing liabilities.
  • The company successfully reduced its exposure to wholesale funding by decreasing FHLB advances and brokered deposits.
  • Capital ratios remain strong, with the Bank's Community Bank Leverage Ratio at 10.40% and the Bancorp's Total Capital ratio at 13.09%, both exceeding regulatory minimums.
  • Accumulated other comprehensive loss decreased, indicating rate improvements on available-for-sale debt securities.

Negatives

  • The company reported a net loss of $4.8 million for the first six months of 2025, a significant reversal from a net income of $8.7 million in the comparable 2024 period.
  • Basic earnings per share for the first six months of 2025 was $(0.33), down from $0.46 in the prior year.
  • Provision for credit losses dramatically increased by $21.2 million for the first six months of 2025, largely due to a $13.7 million specific reserve for a cannabis sector loan and a $3.1 million increase for the Business Express Loan portfolio.
  • Non-accrual loans surged by 127.6% to $101.8 million at June 30, 2025, representing 3.50% of gross loans, indicating significant asset quality deterioration.
  • Net charge-offs increased to $9.9 million for the first six months of 2025, up from $2.9 million in the same period of 2024.
  • The allowance for credit losses coverage of non-accruing loans decreased to 49.8% at June 30, 2025, from 77.8% at December 31, 2024.
  • Total assets decreased by 6.1% and loans receivable, net, decreased by 4.5% from year-end 2024.
  • Total deposits decreased by 3.2% from year-end 2024.
  • Thirteen Business Express loans, with a combined balance of $3.0 million, that were modified during the preceding twelve months subsequently defaulted and were charged-off in full.

Risks

  • Ongoing impact of higher tariffs, inflation, interest rates, and general economic/recessionary concerns on financial transactions and business activities.
  • Challenges in managing liquidity and capital in a rapidly changing and unpredictable market.
  • Increased level of non-performing assets and associated costs for resolution, including litigation.
  • Exposure to global economic trends and geopolitical risks, including conflicts in Ukraine and the Middle East.
  • Unfavorable economic conditions in the primary market areas of New Jersey and New York.
  • Potential for supply chain disruptions and labor shortages impacting customers' businesses.
  • Impact of future pandemics or other natural disasters on operations and financial condition.
  • Ability to effectively attract and deploy deposits in a competitive environment.
  • Risks associated with changes in corporate strategies, asset composition, or funding methods.
  • Shifts in investor sentiment or behavior in financial markets, affecting market liquidity or volatility.
  • Adverse impact of declines in real estate values on the collateral underlying loans.
  • Increased unemployment levels and slowdowns in economic growth affecting loan repayment capacity.
  • Credit risk inherent in the loan portfolio, particularly in commercial real estate, multi-family, and cannabis-related segments.
  • The cannabis industry faces operating challenges, and its federal illegality poses a risk of criminal prosecution and sanctions for borrowers, potentially requiring material future reserves.
  • Ability to access cost-effective funding sources.
  • Legislative and regulatory changes, including potential increases in FDIC insurance rates.
  • Monetary and fiscal policies of federal and state governments, and changes in government priorities.
  • Changes in tax policies, rates, and regulations.
  • Competition for loan products and financial services.
  • Changes in the securities or secondary mortgage markets.
  • Ability to successfully enter new markets or integrate acquired businesses.
  • Changes in consumer spending patterns.
  • Ability to retain key employees.
  • Reputational, interest rate, market, operational, legal, and regulatory risks.
  • Potential impact of regulatory requirements, matters, litigation, or other legal actions.
  • Civil unrest in the communities served.
  • Goodwill impairment risk due to sustained stock price decline and net loss, requiring ongoing assessment.

Future Outlook

Management believes that the current credit quality headwinds are temporary and maintains a positive outlook on the company's long-term earnings power. The company expects to have sufficient funds available to meet current loan commitments through typical sources of liquidity and is well-positioned with adequate cash and liquid assets, along with significant available borrowing capacity from FHLB and Federal Reserve Bank Discount Window. However, the cannabis industry faces ongoing operating challenges, and the company's cannabis portfolio poses an increased amount of credit risk, which could require material reserves in future periods if these headwinds persist.

Management Comments

  • "Management believes that the credit quality headwinds are temporary and the long-term earnings power of the Company maintains a positive outlook."
  • "The Company expects to have sufficient funds available to meet current loan commitments in the normal course of business through typical sources of liquidity."
  • "The Company was well-positioned with adequate levels of cash and liquid assets as of June 30, 2025 and a significant amount of available borrowing capacity with FHLB and Federal Reserve Bank Discount Window."

Industry Context

The banking industry is currently navigating a complex environment characterized by higher interest rates, which can both benefit (higher loan yields) and challenge (higher deposit costs, increased credit risk) banks. The significant increase in non-accrual loans and substantial provision for credit losses, particularly in specific loan segments like cannabis and business express, suggests that BCB Bancorp is experiencing credit quality deterioration that may be more pronounced than some peers, or it could be an early indicator of broader stress in certain loan categories. The focus on reducing wholesale funding is a common strategy in a rising rate environment to manage the cost of funds and improve net interest margin.

Comparison to Industry Standards

  • Net Interest Margin (NIM): BCB Bancorp's NIM of 2.70% (6M 2025) and 2.80% (Q2 2025) is generally in line with or slightly below the average for community banks, which often range from 2.5% to 3.5%. For example, many regional banks like Valley National Bank or Provident Financial Services have reported NIMs in the 3.0-3.5% range in recent quarters, while some smaller community banks might be lower.
  • Asset Quality (Non-accrual loans to gross loans): The increase in non-accrual loans to 3.50% of gross loans at June 30, 2025, is significantly higher than the industry average for well-performing banks, which typically aim for non-accrual rates below 1%. For instance, healthy banks such as M&T Bank or Truist Bank generally report non-performing asset ratios well under 1%. This indicates a notable deterioration in asset quality compared to industry standards.
  • Allowance for Credit Losses (ACL to gross loans): The ACL of 1.74% of gross loans is higher than the 1.15% at year-end, reflecting the increased credit risk. This level of ACL is becoming more common in the current economic climate, but the sharp increase and the specific reserve for cannabis loans highlight particular vulnerabilities. Many large banks have ACLs in the 1.0-1.5% range, while some with higher-risk portfolios might be higher.
  • Capital Ratios: The Bank's Community Bank Leverage Ratio (CBLR) of 10.40% and the Bancorp's Total Capital ratio of 13.09% are well above regulatory minimums (9% and 10% respectively), indicating a strong capital position. This is a positive aspect compared to some banks that might be closer to minimums or facing capital constraints.
  • Loan Portfolio Composition: The significant exposure to commercial real estate, multi-family, and cannabis-related loans, along with the 'Business Express' segment, suggests a higher-risk loan portfolio compared to banks with a more diversified or conservative lending mix. The cannabis sector, in particular, carries unique federal legal risks not present in traditional banking.

Legal Proceedings

  • The company is involved, from time to time, as plaintiff or defendant in various legal actions arising in the normal course of business. As of June 30, 2025, no material legal proceedings were identified that would have a material adverse effect on financial condition or results of operations.

Stakeholder Impact

  • Shareholders: Experienced a net loss for the first six months of 2025 and negative basic EPS, leading to a decrease in retained earnings and overall stockholders' equity. Common stock dividends were declared, but the overall financial performance is concerning.
  • Employees: Salaries and employee benefits increased, indicating continued investment in human capital.
  • Customers: The bank continues to offer a range of deposit and loan products, but increased credit risk in certain loan segments could impact future lending appetite or terms.
  • Creditors (including FHLB): The company reduced FHLB advances, indicating a decrease in reliance on wholesale funding, which is positive for creditors. Subordinated debenture holders face the inherent risks of subordinated debt, though the company's capital ratios remain strong.
  • Regulatory Authorities: The bank continues to exceed all regulatory capital requirements, demonstrating compliance and financial stability from a regulatory perspective, despite asset quality challenges.

Next Steps

  • Management will continue evaluating economic conditions at future reporting periods for goodwill impairment triggering events.
  • The company is currently evaluating the impact of ASU 2023-09 on income tax disclosures, effective for annual periods beginning after December 15, 2024.

Key Dates

DateDescription
2023-04-272023 Equity Incentive Plan approved by shareholders.
2023-09-14Redeemed 22 outstanding shares of Series H 3.5% Noncumulative Perpetual Preferred Stock for $220,000.
2023-12-14Closed private placement of 1,527 shares of Series J Preferred Stock, generating gross proceeds of $15,270,000.
2023-Q4Redeemed remaining 1,101 outstanding shares of Series H 3.5% Noncumulative Perpetual Preferred Stock for $11.0 million.
2024-01-01Beginning balance for six months ended June 30, 2024 financial period.
2024-03-29Closed private placement of 269 shares of Series J Preferred Stock, generating gross proceeds of $2,690,000.
2024-04-25Awards of 30,000 and 20,000 restricted stock shares declared for an executive officer.
2024-06-21Closed private placement of 67 shares of Series J Preferred Stock, generating gross proceeds of $670,000.
2024-08-29Issued $40 million of fixed-to-floating subordinated debentures and repurchased $33.5 million of old subordinated debt.
2024-09-25Closed private placement of 136 shares of Series J Preferred Stock, generating gross proceeds of $1,360,000.
2024-10-31Qualitative assessment of goodwill performed.
2024-12-31Completed private placement of 497 shares of Series K Preferred Stock, generating gross proceeds of $4,970,000.
2025-01-01ASU 2024-02 became effective.
2025-02-03Awards of 43,773 shares of restricted stock declared for Board of Directors members.
2025-02-24Grants of 63,763 stock options declared for certain officers.
2025-03-15Completed private placement of 52 shares of Series K Preferred Stock, generating gross proceeds of $520,000.
2025-05-31Interim goodwill impairment assessment performed due to a triggering event (net loss and sustained stock price decline).
2025-06-30End of the quarterly reporting period.
2025-07-28Board of Directors declared a cash dividend of $0.16 per common share.
2025-08-0117,194,299 shares of common stock outstanding.
2025-08-06Date of filing of the 10-Q report.
2025-08-11Record date for common stock dividend.
2025-08-25Payment date for common stock dividend.
2024-12-15ASU 2023-09 is effective for annual periods beginning after this date.

Recommendation

sell

The company reported a net loss for the first six months of 2025, primarily driven by a massive increase in the provision for credit losses, including a significant specific reserve for a cannabis-related loan. Non-accrual loans have more than doubled, indicating a substantial deterioration in asset quality. While the net interest margin improved and capital ratios remain strong, the escalating credit risk, particularly within the cannabis and Business Express loan portfolios, suggests that future profitability will likely be challenged by continued loan loss provisioning and potential charge-offs. The subsequent defaults of previously modified loans further underscore the persistent credit quality issues. Investors should be wary of the increasing non-performing assets and the potential for further negative impacts on earnings.

Keywords

Banking, Financial Services, Community Bank, Loan Portfolio, Credit Quality, Non-Accrual Loans, Allowance for Credit Losses, Net Interest Margin, Deposits, FHLB Advances, Subordinated Debt, Capital Ratios, Cannabis Lending, Business Express Loans, SEC Filing, 10-Q, Financial Results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.